Blum Holdings (Blum Holdings) Change In Working Capital : $4.99 Mil (TTM As of Sep. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings Change In Working Capital?

Blum Holdings's change in working capital for the quarter that ended in Sep. 2023 was $3.37 Mil.

Blum Holdings's change in working capital for the fiscal year that ended in Dec. 2022 was $14.38 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Blum Holdings Change In Working Capital Historical Data

The historical data trend for Blum Holdings's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blum Holdings Change In Working Capital Chart

Blum Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Working Capital

Get a 7-Day Free Trial

4.27

0.54

2.08

1.47

14.38

Blum Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Working Capital	Get a 7-Day Free Trial															3.18	2.76	-0.25	-0.89	3.37

Blum Holdings Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.99 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Blum Holdings Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Blum Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Blum Holdings (Blum Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705

Website

https://www.unrivaledbrands.com

Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.

Executives

Patty Chan	officer: CHIEF FINANCIAL OFFICER	11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble	officer: President	3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo	director	1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum	director	866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis	director	11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson	director, officer: President and CEO	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone	other: Former Director of Issuer	P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig	officer: Chief Operating Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter	director	C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich	director	2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis	director	205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner	officer: Chief Financial Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez	officer: Chief Financial Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan	director, officer: Chief Executive Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614